Community-based education classes for hypertension control. A 1.5-year randomized controlled trial

Hypertension
H IsoY Komachi

Abstract

Community-based hypertension control is important for primary prevention of cardiovascular disease. In this study, untreated men and women aged 35 to 69 years were randomly assigned to an intervention (n=56) or control (n=55) group in a 1.5-year community-based education program. Subjects had no evidence of hypertensive end-organ defects and had screening blood pressures of 140 to 179 mm Hg systolic and/or 90 to 109 mm Hg diastolic, with no difference in mean blood pressure between groups (148 to 150 mm Hg for mean systolic and 83 to 84 mm Hg for mean diastolic pressures). The intervention group took four education classes in the first 6 months and four classes during the next year, and the control group took two classes. Health education focused on reduced dietary sodium and increased milk intake, brisk walking, and, if necessary, reduction of alcohol and sugar intakes. Antihypertensive medication was started less often in the intervention than in the control group at 1.5 years (9% versus 24%, P <.05). Mean systolic pressure was 5 to 6 mm Hg less in the intervention than in the control group at both 6 months and 1.5 years (P <.05), with or without inclusion of those subjects who began antihypertensive medication. Diastolic pre...Continue Reading

References

Aug 1, 1990·American Journal of Hypertension·J A Cutler, E Brittain
May 1, 1987·European Heart Journal·S MacMahonM Higgins
Oct 22, 1949·Journal of the American Medical Association·C F SAMS

❮ Previous
Next ❯

Citations

Nov 6, 2002·Atherosclerosis·Hironori ImanoTakashi Shimamoto
Jan 11, 2013·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Mitsumasa UmesawaUNKNOWN CIRCS Investigators
Sep 29, 2010·Journal of Health Communication·UNKNOWN United Nations Economic and Social Council (ECOSOC)
Apr 15, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Junko TamakiUNKNOWN HIPOP-OHP Research Group
Apr 2, 2004·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kazumasa YamagishiTakashi Shimamoto
Apr 23, 2010·The Tohoku Journal of Experimental Medicine·Hiroko FujiiAkiko Yamasaki
Aug 12, 2010·Journal of Epidemiology·Yumiko NakashitaHiroshi Mikami
Aug 13, 2009·Journal of Atherosclerosis and Thrombosis·Susumu SakuraiHiroyasu Iso
Apr 24, 2014·American Journal of Hypertension·Jeff WhittleKatie E Mosack
May 20, 2008·Health & Social Care in the Community·Hirohide YokokawaSeiji Yasumura
Mar 4, 2006·Western Journal of Nursing Research·Hulya Cakir, Rukiye Pinar
Jun 12, 2009·The American Journal of Clinical Nutrition·Mitsumasa UmesawaHiroyasu Iso
Feb 16, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Hironori ImanoUNKNOWN CIRCS Investigators
Mar 20, 2010·The Cochrane Database of Systematic Reviews·Liam G GlynnTom Fahey
May 2, 2013·The Cochrane Database of Systematic Reviews·Feng J HeGraham A Macgregor
Jan 21, 2011·The Cochrane Database of Systematic Reviews·Shah EbrahimGeorge Davey Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.